Results of a clinical trial for Point Biopharma’s lead compound fell short of analysts’ expectations, and that development is likely to pressure its investors to decide whether to agree to sell the company to Eli Lilly and Co. for $1.4 billion.
The company’s customers were almost exclusively local until the 2019 holiday season, when a new Foamnasium product, Blocksy, became a hit on social media.
Three years after making its debut as a popular pizza pop-up, Sam’s Square Pie plans to open in January as a full-fledged restaurant near the intersection of East 10th and Rural streets.
Indianapolis officials say they are preparing for more severe weather in the years to come as climate-change events threaten to overwhelm the stormwater drainage system and pose other problems.
It’s a cliché to say someone who just passed away, as basketball legend George McGinnis did early Thursday, was a good person. But he went beyond that. He was nice to a fault. So nice, in fact, that people took advantage of him.
McGinnis’ rose from Indianapolis prep star into an unstoppable force in his one and only college season at Indiana University before eventually taking the Indiana Pacers to two ABA titles.
The Genius School in Indianapolis has lost its bid for a charter from a second authorizer, after the Education One board at Trine University rejected its application Wednesday.
Officials with St. John the Evangelist want to build the 2,800-square-foot facility as part of a larger $5.5 million renovation that started in 2021. They hope to finish in time for the huge National Eucharistic Congress planned for Indianapolis in July.
Latha Ramchand was selected following a national search and will oversee more than 400 undergraduate, graduate, certificate and professional programs, growing research focal areas and an evolving urban campus that serves more than 20,000 students.
In this week’s edition of the IBJ Podcast, Lucas recounts what it was like growing up with hard-charging entrepreneurs as parents, the value of sponsoring Lucas Oil Stadium, and the decision to relocate the firm’s HQ from California to Indianapolis.
The new drug, called Zepbound, carries a hefty price of $1,059.87 per month, and insurers and health care plans are balking, questioning its affordability. Many employers and government health programs exclude obesity treatments from their coverage.
As one of the top mid-major conferences in the country, [the Horizon League] is affected by every single one of these seismic changes, even if that impact isn’t always direct.
